A cancer precision medicine platform for multiple simultaneous genomic assays from metastatic biopsies (bx) in ER plus metastatic breast cancer.

被引：0
|
作者：
Wagle, Nikhil
Helvie, Karla
Lloyd, Maxwell R.
Marini, Lori
Waks, Adrienne Gropper
Cohen, Ofir
Oh, Coyin
Sougnez, Carrie
Oliver, Nelly
Quartey, Qaren
Rotem, Asaf
Shah, Parin
Lindeman, Neal Ian
Krop, Ian E.
Garraway, Levi A.
Winer, Eric P.
Lin, Nancy U.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Broad Inst, Cambridge, MA USA
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.11513
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11513
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Characterization of mutational processes in ER plus metastatic breast cancer.
    Buendia-Buendia, Jorge
    Cohen, Ofir
    Kim, Dewey
    Jain, Esha
    Winer, Eric P.
    Lin, Nancy U.
    Wagle, Nikhil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Lasofoxifene as a potential treatment for ER plus metastatic breast cancer.
    Laine, Muriel
    Fanning, Sean William
    Greene, Marianne
    Chang, Ya-fang
    Phung, Linda
    Tan, Tina T.
    Hiipakka, Richard
    Komm, Barry
    Greene, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Management of metastatic ER plus breast cancer
    Johnston, R. D.
    CANCER RESEARCH, 2017, 77
  • [4] From precision medicine to personalized medicine in metastatic breast cancer patients
    Andre, Fabrice
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [5] Special topics in metastatic ER plus breast cancer
    Mayer, I
    CANCER RESEARCH, 2021, 81 (04)
  • [6] Gemcitabine plus cisplatin in pretreated metastatic breast cancer.
    Moura, G. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Precision medicine improves outcomes in metastatic breast cancer
    Gennari, Alessandra
    NATURE, 2022,
  • [8] Precision medicine for metastatic breast cancer—limitations and solutions
    Monica Arnedos
    Cecile Vicier
    Sherene Loi
    Celine Lefebvre
    Stefan Michiels
    Herve Bonnefoi
    Fabrice Andre
    Nature Reviews Clinical Oncology, 2015, 12 : 693 - 704
  • [9] Safety of limited dose modifications for palbociclib associated neutropenia in ER plus metastatic breast cancer.
    Dominick, Anthony
    O'Dea, Anne
    Khan, Qamar J.
    Kimler, Bruce F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] The genomic profile investigation of metastatic triple-negative breast cancer for precision medicine achievement
    Jang, Wooyeong
    Kim, Jihyun
    Yang, Hanna
    Kwon, Youngmee
    Lee, Keun Seok
    Sim, Sung Hoon
    Kong, Sun-Young
    An, Kyounghee
    Park, In Hae
    Park, Charny
    CANCER RESEARCH, 2018, 78 (13)
12345